ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 88 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$372,000
+30.1%
49,000
-14.2%
0.00%
Q3 2020$286,000
-13.1%
57,087
+3.9%
0.00%
-100.0%
Q2 2020$329,00054,9590.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 2,618,351$41,187,00042.64%
Flagship Pioneering Inc. 38,296,526$602,404,00026.08%
HARBOURVEST PARTNERS LLC 1,973,756$31,048,0005.81%
Artal Group S.A. 2,833,791$44,576,0001.80%
EcoR1 Capital, LLC 463,152$7,285,0000.74%
Cormorant Asset Management, LP 600,000$9,438,0000.54%
Nikko Asset Management Americas, Inc. 1,254,158$19,728,0000.39%
Leap Investments LP 14,100$222,0000.30%
ARK Investment Management 698,402$10,986,0000.28%
Baillie Gifford 4,234,682$66,612,0000.07%
View complete list of RUBIUS THERAPEUTICS INC shareholders